Dementia affects memory, attention, communication, and coordination. One common cause is white matter stroke, a condition in which repeated small strokes gradually damage the brain’s communication networks.
These strokes disrupt the brain’s white matter, the tissue that connects different regions of the brain. As the damage accumulates, cognitive function declines.
Currently, no approved therapies can stop the progression of white matter stroke or significantly boost the brain’s ability to repair itself.
A CIRM-funded study from UCLA suggests that may one day change.
A New Stem Cell Approach for Vascular Dementia
Researchers led by Dr. S. Thomas Carmichael developed an experimental stem cell therapy designed to promote brain repair.
The team used glial cells, which support and protect neurons throughout the central nervous system.
Researchers generated these cells from induced pluripotent stem cells (iPSCs). Scientists create iPSCs by reprogramming adult skin or blood cells into stem cells that can become many different cell types.
The team transplanted the glial cells into mice with brain damage that resembled the early and middle stages of vascular dementia caused by white matter stroke.
Helping the Brain Repair Itself
The transplanted cells traveled to damaged regions of the brain and triggered a surprising response.
Rather than directly replacing damaged tissue, the cells stimulated the brain’s own repair mechanisms.
The therapy prompted the brain’s native stem cells to become more active and begin repairing injured areas.
As a result, researchers observed several important benefits:
- Reduced progression of white matter damage.
- Increased formation of new neural connections.
- Greater production of myelin, the protective coating that surrounds nerve fibers.
- Improved memory and cognitive function.
These changes suggest that the therapy helped rebuild critical communication pathways within the brain.
Francesca Bosetti, PhD, PharmD, of the National Institute of Neurological Disorders and Stroke, called the findings encouraging.
“These preliminary results suggest that glial cell-based therapies may one day help combat the white matter damage that many stroke and vascular dementia patients suffer every year.”
A Treatment That Jump-Starts Recovery
One of the study’s most intriguing findings involved the transplanted cells themselves.
Researchers discovered that removing the transplanted cells several months after treatment did not reverse the benefits.
The mice continued to show signs of recovery.
That result suggests the therapy works by activating the brain’s own repair processes rather than serving as a permanent replacement for damaged cells.
“Because the cell therapy is not directly repairing the brain, you don’t need to rely on the transplanted cells to persist in order for the treatment to be successful,” said Dr. Carmichael.
This approach could offer practical advantages for future therapies because long-term survival of transplanted cells may not be necessary.
Moving Toward Human Clinical Trials
The UCLA team is now conducting the additional studies required to seek approval from the U.S. Food and Drug Administration (FDA) to begin clinical testing.
If future studies confirm the therapy’s safety and effectiveness, researchers envision a one-time treatment for people showing early signs of white matter stroke and vascular dementia.
The need is significant.
As populations age, the number of people living with dementia continues to rise. New treatments that slow disease progression or restore function could profoundly impact patients and families.
While more research remains ahead, this study offers encouraging evidence that regenerative medicine may help the brain repair itself after injury.
The findings were published in Science Translational Medicine.

Seems this approach might be helpful for people living with Multiple Sclerosis.
We certainly hope so James, that would be wonderful wouldn’t it.
Does this study also have positive implications for stem cell treatment of white matter damage in periventricular leukomalacia (PVL)?